Pharmaceutical Law & Industry Report® Table of Cases

Factor VIII or IX Concentrate Blood Prods. Liab. Litig., In re (N.D. Ill.), 96; 466
Farina; U.S. v. (D. Mass.), 316; 885
FDA; Astellas Pharma U.S. Inc. v. (D.D.C.), 967
FDA; Hi-Tech Pharmacal Co. v. (D.D.C.), 8
FDA; Sanofi-Aventis U.S. LLC v. (D.D.C.), 963
FDA; Wyeth Pharms. Inc. v. (D.D.C.), 1099; 1130
Federal Trade Comm'n

See FTC

Ferris State Univ.; Change to Win v. (Mich. Cir. Ct.), 283
F. Hoffmann-La Roche Ltd.; Amgen Inc. v. (Fed. Cir.), 1097
Fields v. Wyeth Inc. (W.D. Ark.), 614
First Databank Inc.; New England Carpenters Health Benefits Fund v. (D. Mass.), 307; 500; 909; (1st Cir.), 553
Fleeger v. Wyeth (Minn.), 1036
Food and Drug Admin.

See FDA

Forest Labs. Inc. v. Caraco Pharm. Labs. Ltd. (U.S., rev den), 227; (E.D. Mich.), 462
Forest Labs. Inc. v. Cobalt Labs. Inc. (D. Del.), 1100
Forest Labs. Inc.; U.S. ex rel. Gobble v. (D. Mass.), 226; 1166
Forest Labs. Inc.; U.S. ex rel. Piacentile v. (D. Mass.), 226; 1166
Forst v. SmithKline Beecham Corp. (E.D. Wis.), 910
Fosamax Prods. Liab. Litig., In re (S.D.N.Y.), 315; 1069; 1170
Frey v. Novartis Pharms. Corp. (S.D. Ohio), 970
FTC v. Bristol-Myers Squibb (D.D.C.), 371
FTC v. Lundbeck Inc. (D. Minn.), 851
FTC v. Tarriff (D.C. Cir.), 1253
FTC v. Watson Pharms. Inc. (C.D. Cal.), 145; 435